The multipotential pseudoantigenicity of X-ray contrast media. Pseudoantigen excess may downregulate the release of hypotensive mediators
- PMID: 11146385
- DOI: 10.1159/000053640
The multipotential pseudoantigenicity of X-ray contrast media. Pseudoantigen excess may downregulate the release of hypotensive mediators
Erratum in
- Int Arch Allergy Immunol. 2002 Dec;129(4):350.
Abstract
Background: X-ray contrast media (CM) toxicity resembles IgE-antigen-based anaphylaxis, and CM-related histamine release has been demonstrated in vitro and in vivo. While nobody has succeeded in producing antibodies against injections of neat CM, the ability of CM to compete with a series of antigens against their respective antibodies has recently been demonstrated. However, there is a paradox, since the CM with the strongest antibody binding are nevertheless the least likely to provoke antigen-antibody-related mast cell/basophil release.
Methods: Two strains of rats were subjected to (a) passive cutaneous anaphylaxis (PCA) studies in the presence of various concentrations of CM, (b) blood pressure (BP) tracings following bolus administrations of various prototypical CM and (c) BP tracings in ovalbumin (OVA)-sensitized rats, challenged with OVA plus CM, vs. OVA plus CM-equivalent saline.
Results: In the PCA studies, and the OVA challenge studies, the CM appear to act in an antigen excess mode, limiting the potential of the OVA to elicit anaphylactic changes, as demonstrated by permeability studies or by BP levels. The bolus CM studies demonstrate that the more potent CM 'antigens' actually produce an increase in BP and the less potent CM 'antigens', a drop in BP. These changes can be related to the CM acting in an 'antigen' excess mode vs. an 'antigen' equivalent mode.
Conclusions: The CM have the potential to act in an 'antigen' excess or 'antigen'-equivalent mode. The potential to express an 'antigen'-excess mode in vivo, may be unique to CM because of the high concentrations injected.
Copyright 2000 S. Karger AG, Basel
Similar articles
-
Brown Norway rat ovalbumin-specific immunoglobulin E antibodies increase the human basophil expression of CD63 marker.Scand J Immunol. 2003 Mar;57(3):271-8. doi: 10.1046/j.1365-3083.2003.01233.x. Scand J Immunol. 2003. PMID: 12641656
-
The radiocontrast molecule in anaphylaxis: a surprising antigen.Novartis Found Symp. 2004;257:211-24; discussion 224-5, 276-85. Novartis Found Symp. 2004. PMID: 15025400
-
Effect of myeloma IgE injections on passive and active cutaneous anaphylaxis in rats.J Immunol. 1986 Jan;136(1):131-5. J Immunol. 1986. PMID: 3484388
-
Experimental investigations with iohexol and their clinical relevance.Acta Radiol Suppl. 1983;366:9-19. Acta Radiol Suppl. 1983. PMID: 6206690 Review.
-
Adverse reactions to intravascular administration of contrast media.Allergy. 1981 Aug;36(6):369-73. doi: 10.1111/j.1398-9995.1981.tb01840.x. Allergy. 1981. PMID: 6172047 Review.
Cited by
-
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.Drug Saf. 2005;28(6):547-56. doi: 10.2165/00002018-200528060-00006. Drug Saf. 2005. PMID: 15924506
-
Current understanding of contrast media reactions and implications for clinical management.Drug Saf. 2006;29(2):133-41. doi: 10.2165/00002018-200629020-00003. Drug Saf. 2006. PMID: 16454540 Review.
-
Hypersensitivity Reactions to Iodinated Contrast Media.Biomedicines. 2022 Apr 30;10(5):1036. doi: 10.3390/biomedicines10051036. Biomedicines. 2022. PMID: 35625773 Free PMC article. Review.
-
Bridging the gap between bench and clinic: the importance of understanding the mechanism of iodinated contrast media hypersensitivity.Br J Radiol. 2023 Jan 1;96(1141):20220494. doi: 10.1259/bjr.20220494. Epub 2022 Dec 7. Br J Radiol. 2023. PMID: 36395475 Free PMC article. Review.
-
Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube®: a randomized clinical trial.J Asthma Allergy. 2019 Mar 1;12:71-81. doi: 10.2147/JAA.S150251. eCollection 2019. J Asthma Allergy. 2019. PMID: 30881050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources